Cys-27 variant of human δ-opioid receptor modulates maturation and cell surface delivery of Phe-27 variant via heteromerization

Journal of Biological Chemistry

Volumn 287, Issue 7, 2012, Pages 5008-5020

  Leskelä, Tarja T ^a   Lackman, Jarkko J ^a   Vierimaa, Miia M ^a   Kobayashi, Hiroyuki ^b,c   Bouvier, Michel ^b,c   Petäjä Repo, Ulla E ^a  

^a UNIVERSITY OF OULU   (Finland)

^b INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLUMINESCENCE RESONANCE ENERGY TRANSFER; CELL SURFACE EXPRESSION; CELL SURFACES; CO-IMMUNOPRECIPITATIONS; DOMINANT NEGATIVE; ENDOPLASMIC RETICULUM; G PROTEIN COUPLED RECEPTORS; HEK-293; LIVING CELL; METABOLIC LABELING; NALTREXONE; NEUROBLASTOMA CELLS; OPIOID RECEPTORS; SECRETORY PATHWAYS; WESTERN BLOTTING;

CONFOCAL MICROSCOPY; FLOW CYTOMETRY;

CELL MEMBRANES;

CYSTEINE; DELTA OPIATE RECEPTOR; NALTREXONE; PHENYLALANINE;

ARTICLE; BIOLUMINESCENCE RESONANCE ENERGY TRANSFER; CELL LABELING; CELL MATURATION; CELL STRAIN HEK293; CELL STRAIN SH SY5Y; CELL SURFACE; COMPLEX FORMATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENDOPLASMIC RETICULUM ASSOCIATED DEGRADATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; INTRACELLULAR SIGNALING; INTRACELLULAR TRANSPORT; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN HETEROMERIZATION; PROTEIN MODIFICATION; PROTEIN POLYMORPHISM; RECEPTOR DENSITY; WESTERN BLOTTING;

CELL LINE, TUMOR; ENDOPLASMIC RETICULUM; HEK293 CELLS; HUMANS; NALTREXONE; NARCOTIC ANTAGONISTS; PHENYLALANINE; PROTEIN MULTIMERIZATION; PROTEIN PRECURSORS; PROTEIN TRANSPORT; PROTEOLYSIS; RECEPTORS, OPIOID, DELTA;

EID: 84856866923     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M111.305656     Document Type: Article

References (52)

1. Waldhoer, M., Bartlett, S. E., and Whistler, J. L. (2004) Opioid receptors. Annu. Rev. Biochem. 73, 953-990 (Pubitemid 39050391)
2. Gelernter, J., and Kranzler, H. R. (2000) Variant detection at the δ-opioid receptor (OPRD1) locus and population genetics of a novel variant affecting protein sequence. Hum. Genet 107, 86-88 (Pubitemid 30598953)
3. Sarajärvi, T., Tuusa, J. T., Haapasalo, A., Lackman, J. J., Sormunen, R., Helisalmi, S., Roehr, J. T., Parrado, A. R., Mäkinen, P., Bertram, L., Soininen, H., Tanzi, R. E., Petäjä-Repo, U. E., and Hiltunen, M. (2011) Cysteine 27 variant of the δ-opioid receptor affects amyloid precursor protein processing through altered endocytic trafficking. Mol. Cell. Biol. 31, 2326-2340
4. Leskelä, T. T., Markkanen, P. M., Alahuhta, I. A., Tuusa, J. T., and Petäjä- Repo, U. E. (2009) Phe27Cys polymorphism alters the maturation and subcellular localization of the human δ-opioid receptor. Traffic 10, 116-129
5. Petäjä-Repo, U. E., Hogue, M., Bhalla, S., Laperrière, A., Morello, J. P., and Bouvier, M. (2002) Ligands act as pharmacological chaperones and increase the efficiency of δ-opioid receptor maturation. EMBO J. 21, 1628-1637 (Pubitemid 34614619)
6. Leskelä, T. T., Markkanen, P. M., Pietilä, E. M., Tuusa, J. T., and Petäjä- Repo, U. E. (2007) Opioid receptor pharmacological chaperones act by binding and stabilizing newly synthesized receptors in the endoplasmic reticulum. J. Biol. Chem. 282, 23171-23183
7. Cvejic, S., and Devi, L. A. (1997) Dimerization of the δ-opioid receptor. Implication for a role in receptor internalization. J. Biol. Chem. 272, 26959-26964 (Pubitemid 27452648)
8. Jordan, B. A., and Devi, L. A. (1999) G protein-coupled receptor heterodimerization modulates receptor function. Nature 399, 697-700 (Pubitemid 29289066)
9. McVey, M., Ramsay, D., Kellett, E., Rees, S., Wilson, S., Pope, A. J., and Milligan, G. (2001) Monitoring receptor oligomerization using time-resolved fluorescence resonance energy transfer and bioluminescence resonance energy transfer. The human δ-opioid receptor displays constitutive oligomerization at the cell surface, which is not regulated by receptor occupancy. J. Biol. Chem. 276, 14092-14099
10. Ramsay, D., Kellett, E., McVey, M., Rees, S., and Milligan, G. (2002) Homo- and hetero-oligomeric interactions between G protein-coupled receptors in living cells monitored by two variants of bioluminescence resonance energy transfer (BRET). Hetero-oligomers between receptor subtypes form more efficiently than between less closely related sequences. Biochem. J. 365, 429-440 (Pubitemid 36135314)
11. Wang, D., Sun, X., Bohn, L. M., and Sadée, W. (2005) Opioid receptor homo- and heterodimerization in living cells by quantitative bioluminescence resonance energy transfer. Mol. Pharmacol. 67, 2173-2184 (Pubitemid 41007796)
12. Xie, Z., Bhushan, R. G., Daniels, D. J., and Portoghese, P. S. (2005) Interaction of bivalent ligand KDN21 with heterodimeric δ-κ-opioid receptors in human embryonic kidney 293 cells. Mol. Pharmacol. 68, 1079 -1086
13. Waldhoer, M., Fong, J., Jones, R. M., Lunzer, M. M., Sharma, S. K., Koste-nis, E., Portoghese, P. S., and Whistler, J. L. (2005) A heterodimer-selective agonist shows in vivo relevance of G protein-coupled receptor dimers. Proc. Natl. Acad. Sci. U.S.A. 102, 9050-9055 (Pubitemid 40881076)
14. Breit, A., Gagnidze, K., Devi, L. A., Lagacé, M., and Bouvier, M. (2006) Simultaneous activation of the δ-opioid receptor (δ-OR)/sensory neuron-specific receptor-4 (SNSR-4) hetero-oligomer by the mixed bivalent agonist bovine adrenal medulla peptide 22 activates SNSR-4 but inhibits δOR signaling. Mol. Pharmacol. 70, 686-696 (Pubitemid 44092329)
15. Hasbi, A., Nguyen, T., Fan, T., Cheng, R., Rashid, A., Alijaniaram, M., Rasenick, M. M., O'Dowd, B. F., and George, S. R. (2007) Trafficking of preassembled opioid μ-δ heterooligomer-Gz signaling complexes to the plasma membrane. Coregulation by agonists. Biochemistry 46, 12997-13009 (Pubitemid 350086219)
16. Parenty, G., Appelbe, S., and Milligan, G. (2008) CXCR2 chemokine receptor antagonism enhances DOP opioid receptor function via allosteric regulation of the CXCR2-DOP receptor heterodimer. Biochem. J. 412, 245-256 (Pubitemid 351758230)
17. Gupta, A., Mulder, J., Gomes, I., Rozenfeld, R., Bushlin, I., Ong, E., Lim, M., Maillet, E., Junek, M., Cahill, C. M., Harkany, T., and Devi, L. A. (2010) Increased abundance of opioid receptor heteromers after chronic morphine administration. Sci. Signal. 3, ra54
18. van Rijn, R. M., Whistler, J. L., and Waldhoer, M. (2010) Opioid receptor heteromer-specific trafficking and pharmacology. Curr. Opin. Pharmacol. 10, 73-79
19. Rozenfeld, R., and Devi, L. A. (2011) Exploring a role for heteromerization in GPCR signalling specificity. Biochem. J. 433, 11-18
20. Kniazeff, J., Prézeau, L., Rondard, P., Pin, J. P., and Goudet, C. (2011) Dimers and beyond. The functional puzzles of class C GPCRs. Pharmacol. Ther. 130, 9-25
21. Bulenger, S., Marullo, S., and Bouvier, M. (2005) Emerging role of homo- and heterodimerization in G protein-coupled receptor biosynthesis and maturation. Trends Pharmacol. Sci. 26, 131-137 (Pubitemid 40313592)
22. Rajan, R. S., and Kopito, R. R. (2005) Suppression of wild-type rhodopsin maturation by mutants linked to autosomal dominant retinitis pigmentosa. J. Biol. Chem. 280, 1284-1291
23. Karpa, K. D., Lin, R., Kabbani, N., and Levenson, R. (2000) The dopamine D3 receptor interacts with itself and the truncated D3 splice variant d3nf. D3-D3nf interaction causes mislocalization of D3 receptors. Mol. Pharmacol. 58, 677-683
24. Lee, S. P., O'Dowd, B. F., Ng, G. Y., Varghese, G., Akil, H., Mansour, A., Nguyen, T., and George, S. R. (2000) Inhibition of cell surface expression by mutant receptors demonstrates that D2 dopamine receptors exist as oligomers in the cell. Mol. Pharmacol. 58, 120-128 (Pubitemid 30452534)
25. Grosse, R., Schöneberg, T., Schultz, G., and Gudermann, T. (1997) Inhibition of gonadotropin-releasing hormone receptor signaling by expression of a splice variant of the human receptor. Mol. Endocrinol. 11, 1305-1318 (Pubitemid 28041337)
26. Brothers, S. P., Cornea, A., Janovick, J. A., and Conn, P. M. (2004) Human loss-of-function gonadotropin-releasing hormone receptor mutants retain wild-type receptors in the endoplasmic reticulum. Molecular basis of the dominant-negative effect. Mol. Endocrinol. 18, 1787-1797 (Pubitemid 38859584)
27. Sánchez-Laorden, B. L., Sánchez-Más, J., Martínez-Alonso, E., Martínez-Menárguez, J. A., García-Borrón, J. C., and Jiménez-Cervantes, C. (2006) Dimerization of the human melanocortin 1 receptor. Functional consequences and dominant-negative effects. J. Invest. Dermatol. 126, 172-181
28. Beaumont, K. A., Shekar, S. N., Shekar, S. L., Newton, R. A., James, M. R., Stow, J. L., Duffy, D. L., and Sturm, R. A. (2007) Receptor function, dominant negative activity, and phenotype correlations for MC1R variant alleles. Hum. Mol. Genet 16, 2249-2260 (Pubitemid 47354907)
29. Calebiro, D., de Filippis, T., Lucchi, S., Covino, C., Panigone, S., Beck-Peccoz, P., Dunlap, D., and Persani, L. (2005) Intracellular entrapment of wild-type TSH receptor by oligomerization with mutants linked to dominant TSH resistance. Hum. Mol. Genet 14, 2991-3002 (Pubitemid 41535464)
30. Apaja, P. M., Tuusa, J. T., Pietilä, E. M., Rajaniemi, H. J., and Petäjä-Repo, U. E. (2006) Luteinizing hormone receptor ectodomain splice variant misroutes the full-length receptor into a subcompartment of the endoplasmic reticulum. Mol. Biol. Cell 17, 2243-2255 (Pubitemid 44011740)
31. Benkirane, M., Jin, D. Y., Chun, R. F., Koup, R. A., and Jeang, K. T. (1997) Mechanism of transdominant inhibition of CCR5-mediated HIV-1 infection by ccr5delta32. J. Biol. Chem. 272, 30603-30606 (Pubitemid 27527488)
32. Shioda, T., Nakayama, E. E., Tanaka, Y., Xin, X., Liu, H., Kawana-Tachikawa, A., Kato, A., Sakai, Y., Nagai, Y., and Iwamoto, A. (2001) Naturally occurring deletional mutation in the C-terminal cytoplasmic tail of CCR5 affects surface trafficking of CCR5. J. Virol. 75, 3462-3468 (Pubitemid 32225909)
33. Zhu, X., and Wess, J. (1998) Truncated V2 vasopressin receptors as negative regulators of wild-type V2 receptor function. Biochemistry 37, 15773-15784 (Pubitemid 28524748)
34. Hague, C., Uberti, M. A., Chen, Z., Hall, R. A., and Minneman, K. P. (2004) Cell surface expression of α1D-adrenergic receptors is controlled by heterodimerization with α1B-adrenergic receptors. J. Biol. Chem. 279, 15541-15549 (Pubitemid 38618955)
35. Canals, M., Lopez-Gimenez, J. F., and Milligan, G. (2009) Cell surface delivery and structural reorganization by pharmacological chaperones of an oligomerization-defective α (1b)-adrenoceptor mutant demonstrates membrane targeting of GPCR oligomers. Biochem. J. 417, 161-172
36. Kobayashi, H., Ogawa, K., Yao, R., Lichtarge, O., and Bouvier, M. (2009) Functional rescue of β-adrenoceptor dimerization and trafficking by pharmacological chaperones. Traffic 10, 1019-1033
37. Law, P. Y., Erickson-Herbrandson, L. J., Zha, Q. Q., Solberg, J., Chu, J., Sarre, A., and Loh, H. H. (2005) Heterodimerization of μ- and δ-opioid receptors occurs at the cell surface only and requires receptor-G protein interactions. J. Biol. Chem. 280, 11152-11164 (Pubitemid 40418422)
38. Pietilä, E. M., Tuusa, J. T., Apaja, P. M., Aatsinki, J. T., Hakalahti, A. E., Rajaniemi, H. J., and Petäjä-Repo, U. E. (2005) Inefficient maturation of the rat luteinizing hormone receptor. A putative way to regulate receptor numbers at the cell surface. J. Biol. Chem. 280, 26622-26629
39. Tuusa, J. T., Leskelä, T. T., and Petäjä-Repo, U. E. (2010) Human δ-opioid receptor biogenesis is regulated via interactions with SERCA2b and calnexin. FEBS J. 277, 2815-2829
40. Nagai, T., Ibata, K., Park, E. S., Kubota, M., Mikoshiba, K., and Miyawaki, A. (2002) A variant of yellow fluorescent protein with fast and efficient maturation for cell-biological applications. Nat. Biotechnol. 20, 87-90 (Pubitemid 34044921)
41. Villemure, J. F., Adam, L., Bevan, N. J., Gearing, K., Chénier, S., and Bouvier, M. (2005) Subcellular distribution of GABA(B) receptor homo- and heterodimers. Biochem. J. 388, 47-55 (Pubitemid 40732931)
42. Petaja-Repo, U. E., Hogue, M., Laperriere, A., Bhalla, S., Walker, P., and Bouvier, M. (2001) Newly synthesized human δ-opioid receptors retained in the endoplasmic reticulum are retrotranslocated to the cytosol, deglycosylated, ubiquitinated, and degraded by the proteasome. J. Biol. Chem. 276, 4416-4423
43. Petäjä-Repo, U. E., Hogue, M., Leskelä, T. T., Markkanen, P. M., Tuusa, J. T., and Bouvier, M. (2006) Distinct subcellular localization for constitutive and agonist-modulated palmitoylation of the human δ-opioid receptor. J. Biol. Chem. 281, 15780-15789 (Pubitemid 43848468)
44. Markkanen, P. M., and Petäjä-Repo, U. E. (2008) N-Glycan-mediated quality control in the endoplasmic reticulum is required for the expression of correctly folded δ-opioid receptors at the cell surface. J. Biol. Chem. 283, 29086-29098
45. Yang, B., Hoe, M. H., Black, P., and Hunt, R. C. (1993) Role of oligosaccharides in the processing and function of human transferrin receptors. Effect of the loss of the three N-glycosyl oligosaccharides individually or together. J. Biol. Chem. 268, 7435-7441 (Pubitemid 23105639)
46. Do, S. I., and Cummings, R. D. (1992) Presence of O-linked oligosaccharide on a threonine residue in the human transferrin receptor. Glycobiology 2, 345-353
47. i/o-coupled receptors compete for signaling to adenylyl cyclase in SH-SY5Y cells and reduce opioid-mediated cAMP overshoot. Mol. Pharmacol. 79, 461-471
48. Mercier, J. F., Salahpour, A., Angers, S., Breit, A., and Bouvier, M. (2002) Quantitative assessment of β1- and β2-adrenergic receptor homo- and heterodimerization by bioluminescence resonance energy transfer. J. Biol. Chem. 277, 44925-44931 (Pubitemid 36159089)
49. George, S. R., Fan, T., Xie, Z., Tse, R., Tam, V., Varghese, G., and O'Dowd, B. F. (2000) Oligomerization of μ- and δ-opioid receptors. Generation of novel functional properties. J. Biol. Chem. 275, 26128-26135
50. Salahpour, A., Angers, S., Mercier, J. F., Lagacé, M., Marullo, S., and Bouvier, M. (2004) Homodimerization of the δ2-adrenergic receptor as a prerequisite for cell surface targeting. J. Biol. Chem. 279, 33390-33397 (Pubitemid 39062987)
51. Terrillon, S., Durroux, T., Mouillac, B., Breit, A., Ayoub, M. A., Taulan, M., Jockers, R., Barberis, C., and Bouvier, M. (2003) Oxytocin and vasopressin V1a and V2 receptors form constitutive homo- and heterodimers during biosynthesis. Mol. Endocrinol. 17, 677-691 (Pubitemid 36403579)
52. Okiyoneda, T., Apaja, P. M., and Lukacs, G. L. (2011) Protein quality control at the plasma membrane. Curr. Opin. Cell Biol. 23, 483-491